The Potential Role of Serum Endothelin-1 Correlated with Intraocular Pressure in Primary Open Angle Glaucoma: A Cross Sectional Study in North Sumatera-Indonesia
Abstract
Glaucoma is the second leading cause of blindness worldwide with the incidence of open-angle glaucoma more frequent than closed-angle glaucoma. Vascular endothelial cells producing peptide named ET-1, causing vasoconstrictor effects on arteries and veins with increasing blood pressure. ET-1 is considered as a potential contributor in the pathogenesis of glaucoma. This study is aimed at analysing the serum ET-1 level in Primary Open Angle Glaucoma (POAG) patients. This prospective, analytic observational with cross sectional study was conducted in Universitas Sumatera Utara Hospital and Satellite Hospital, Medan, Indonesia from December 2018 to February 2019. The sample of this study are 24 POAG patients and 24 normal subjects as a control. The patients were investigated for ophthalmology examination including visual acuity, intraocular pressure, retinal nerve fiber layer (RNFL) thickness and visual field defect. The serum ET-1 was examinated by ELISA. Serum ET-1 level correlated with higher IOP in patient with primary open angle glaucoma. Although no specific correlation can be deduced from this, effect of ET-1 still needed investigation.
Keywords: Endothelin-1, Intraocular Pressure, Primary Open Angle Glaucoma, Serum
Downloads
Issue
Section
License
Terms and conditions of Creative Commons Attribution 4.0 International License apply to all published manuscripts. This Journal is licensed under a Creative Commons Attribution 4.0 International License. This licence allows authors to use all articles, data sets, graphics and appendices in data mining applications, search engines, web sites, blogs and other platforms by providing appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
A competing interest exists when professional judgment concerning the validity of research is influenced by a secondary interest, such as financial gain. We require that our authors reveal all possible conflicts of interest in their submitted manuscripts.
The Editor reserves the right to shorten and adjust texts. Significant changes in the text will be agreed with the Authors.